Immunological and endocrine aspects of pathogenesis of depression;Immunologiczne i endokrynologiczne aspekty patogenezy depresji

Postepy Psychiatrii i Neurologii

Volumn 16, Issue 4, 2007, Pages 335-337

  Ryś, Anna ^a   Miodek, Anna ^a   Szemraj, Paweł ^a   Szemraj, Janusz ^b   Kocur, Józef ^b  

^a Oddzial VIII B ^*  (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Adrenal axis; Cytokines Hypothalamic; Pituitary

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GLUCOCORTICOID; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL ACTIVITY; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CYTOKINE RELEASE; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENDOCRINE DISEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE COUNT; NATURAL KILLER CELL; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; REVIEW; STRESS; T LYMPHOCYTE;

EID: 77953437133     PISSN: 12302813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Jacobs BL, van Praag H, Gage FH. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 2000; 5: 262-9.
2. McEwen BS, Magarinos AM. Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum Psychopharmacol 2001; 16: S7-S19.
3. Dantzer R, Wollman E, Vitkovic L, Yirmiya R. Cytokines and depression: Fortuitous or causative association? Mol Psychiatry 1999; 4: 328-32.
4. Licinio J, Wong ML. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 1999; 4: 317-27.
5. Jakóbisiak M. Immunologia. PWN; 1998: 263-80.
6. Costa JV, Duarte JS. Adipose tissue and adipokines. Acta Med Port 2006; 19 (3): 251-6.
7. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study. Eur Heart J 2007; 28 (3): 354-62.
8. Lim W, Hong S, Nelesen R, Dimsdale JF. The association of obesity, cytokine levels, and depressive symptoms with diverse measures of fatigue in healthy subjects. Arch Intern Med 2005; 165 (8): 910-5.
9. Anisman H, Merali Z, Poulter MO, Hayley S. Cytokines as a precipitant of depressive illness: animal and human studies. Curr Pharm Des 2005; 11 (8): 963-72.
10. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin-6. Immunol Today 1990; 170: 443-9.
11. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-59.
12. Lyness JM, Moynihan JA, Caine ED. Inflammatory markers, depression, and cardiac disease. Am J Psychiatry 2005; 162 (1): 195.
13. Reichlin S. Neuroendocrine-immune interactions. N Engl J Med 1993; 329: 1246-53.
14. Minor TR, Huang Q, Witt AE. Cytokine-purine interactions in traumatic stress, behavioral depression, and sickness. CNS Neurol Disord Drug Targets 2006; 5: 547-60.
15. Blalock JE. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev 1989; 69: 1-32.
16. Reichlin S. Neuroendocrine-immune interactions. N Engl J Med 1993; 329: 1246-53.
17. Kent S, Bluthe RM, Kelley KW, Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci 1992; 13: 24-8.
18. Yirmiya R. Endotoxin produces depressive-like episode in rats. Brain Res 1996; 711: 163-74.
19. Smith RS. The macrophage theory of depression. Medical Hypotheses 1991; 35: 298-306.
20. Kubera M. Cytokinowa teoria depresji. Post Psychiatr Neurol 2004; supl 1 (17): 35-41.
21. Hauser P, Khosla I, Aurora H, Laurin J, Kling MA, Hill J, Gulati M, Thornton AJ, Schultz RL, Valentine AD, Meyers CA, Howell CD. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry 2002; 7: 942-7.
22. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH. Paroxetine for the prevention of depression induced by highdose interferon-α. N Engl J Med 2001; 344: 961-6.
23. Vereker E, O'Donnell E, Lynch MA. The inhibitory effect of interleukin-1-beta on long term potentiation is coupled with increased activity of stress - activated protein kinases. J Neurosci 2000; 20: 6811-9.
24. Jehn CF, Kuehnhardt D, Bartholomae A, Pfeiffer S, Krebs M, Regierer AC, Schmid P, Possinger K, Flath BC. Biomarkers of depression in cancer patients. Cancer 2006; 107 (11): 2723-9.
25. Budziszewska B, Lasoń W. Immunologia mózgu. Triangulum MBP. Wrocław: 2003; 4-12.
26. McLean KM, Duffy JY, Pandalai PK, Lyons JM, Bulcao CF, Wagner CJ, Akhter SA, Pearl JM. Glucocorticoids alter the balance between pro- and anti-inflammatory mediators in the myocardium in a porcine model of brain death. J Heart Lung Transplant 2007; 26 (1): 78-84.
27. Landowski J. Neuroendokrynologia. W: Bilikiewicz A, Puzyński S, Rybakowski J, Wciórka J, red. Psychiatria. Wrocław: Urban & Partner; 2002: 191-203.